QUATTRO TEAM
FOCUSED TEAMS WITH EXPERT LEADERSHIP
We sometimes like to think of Quattro as a Special Forces team for growth. We are not for every mission. However, if you have a vital growth challenge, you have come to the right place. That’s all we do.
PATRICK MROTEK
FOUNDER + MANAGING DIRECTOR
PATRICK MROTEK
FOUNDER + MANAGING DIRECTOR
Patrick Mrotek has provided strategic advice to Chief Executive Officers, Board members, and senior management in the medical industry for over three decades. He was a co-Founder in 1992 of Quattro Consulting Inc.
During Patrick’s tenure as a Managing Director of Quattro, he has led an extensive array of growth assessment and strategy development teams, successfully identifying opportunities and navigating risks in both US and international markets. Under his leadership, Quattro teams have earned their reputation for thorough research, rigorous analysis, candid discussion, and compelling results.
In his work Patrick has carefully researched and reviewed thousands of primary and secondary information sources on an extensive array of medical issues, products and companies. Before Quattro, Patrick was with Bain & Company where he also worked in the healthcare practice.
His undergraduate degree is from Auburn University in Montgomery where he received his BS in Mathematics with Highest Honors. Patrick subsequently completed his MBA at Stanford University Graduate School of Business in Palo Alto, California.
ANN COLISTER
FOUNDER + MANAGING DIRECTOR
ANN COLISTER
FOUNDER + MANAGING DIRECTOR
Ann is a co-Founder and Managing Director of Quattro Consulting Inc. In her work at Quattro since 1992, Ann has fostered the company’s highly creative yet pragmatic approach to answering complex growth questions facing medical companies, from Fortune 500 firms to start-ups.
For more than 25 years, on behalf of Quattro clients, she has personally interviewed thousands of physicians in the US, Europe and Asia covering a vastly diverse range of medical topics. Distilling insights from the divergent opinions inherent in medicine has given Ann an exceptional perspective on physician needs and motivations as well as the challenges and opportunities companies face in growth.
Before founding Quattro, Ann worked as a consultant in Bain & Company’s healthcare practice. Prior to healthcare, she was a Captain and Company Commander in the US Army.
Ann also has the unique distinction of being a member of the first class of women at West Point, and she holds a BS in Engineering from there. She received her MBA from Stanford University.
STAN DERESINSKI,
MD FACP FIDSA
CHIEF MEDICAL ADVISOR
MD FACP FIDSA
DR. STANLEY DERESINSKI,
MD, FACP
CHIEF MEDICAL ADVISOR
MD, FACP
Dr. Stan Deresinski is Clinical Professor of Medicine at Stanford University School of Medicine in Palo Alto, California in the Division of Infectious Diseases and Geographic Medicine as well as Medical Director of the Antimicrobial Stewardship Program.
Dr. Deresinski received his medical degree from the University of Illinois College of Medicine, where he also completed two years of training in Internal Medicine. His training was then interrupted by 2 years of U.S. Army service, starting with a tour in Vietnam. He completed his Internal Medicine residency at Stanford University where he then received 3 years of training in Infectious Diseases. His career and experience have been long and varied. In addition to serving as a physician in the military, he has worked at Veterans Administration hospital and a public county hospital, as well as at both a university hospital and a private community hospital.
He maintained a private practice in Infectious Disease, HIV, and Travel Medicine in Redwood City, California and was Hospital Epidemiologist at Sequoia Hospital where he served as President of the Medical Staff for 2 years. During most of that time he was also Associate Chief of the Division of Infectious Diseases and Director of the AIDS Program at the Santa Valley Medical Center. In 1987, he founded the AIDS Community Research Consortium, serving as its Medical Director and Chairman of the Board for almost 2 decades. He was also Site Principal Investigator for the Stanford AIDS Clinical Trials Unit and the California Collaborative Treatment Group. Dr. Deresinski is currently Clinical Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford and is Medical Director of the Stanford Antimicrobial Stewardship Program as well as Chair of the Pharmacy and Therapeutics Committee.
In addition to multiple book chapters, Dr. Deresinski has published more than 140 peer-reviewed articles dealing with a broad range of infectious. He has also been Editor of Infectious Disease Alert since 1992 and Section Editor of Clinical Infectious Diseases since 2005. In addition, he has served as a consultant to industry.
Dr. Deresinski is a Fellow of the American College of Physicians, the Infectious Diseases Society of America (IDSA), and the European Society of Clinical Microbiology and Infectious Diseases.
He has also received the Certificate of Knowledge in Clinical Tropical Medicine and Travelers Health from the American Society of Tropical Medicine and Hygiene and is a member of the HIVMA and SHEA. He was a member of the IDSA Standards and Practice Guidelines Committee (SPGC) from 2005-2008 and then served as Chair of that committee from 2005-2008. Dr. Deresinski was a member of the IDSA Board of Directors from 2012-2015. He is a past member of the Society of Healthcare Epidemiologists of America (SHEA) Antimicrobial Stewardship Committee and is a current member of the Advisory Committee of the Antimicrobial Stewardship Program of the Center for Infectious Disease Research and Policy (CIDRAP). He recently served on an expert panel dealing with antimicrobial resistance for the General Accounting Office in response to a request from Congress.
Dr. Deresinski has also recently served on the HICPAC working group addressing the issue of incorporation of stewardship principles into IDSA guidelines as well as a CDC external expert dealing with development and implementation of the Standardized Antimicrobial Administration Ratio (SAAR), a metric designed to allow comparison of antimicrobial use at institutions throughout the U.S. Dr. Deresinski has received a number of teaching awards at Stanford and is a past recipient of the Watanakunakorn Award given by the Infectious Diseases Society of America (IDSA) to the best clinician of the year.
Dr. Deresinski established the Stanford Antimicrobial Safety and Sustainability (SASS) program in 2012 (http://med.stanford.edu/bugsanddrugs.html). The program has developed multiple online courses dealing with antimicrobials, one of which has been accessed by more than 130,000 registrants from more than 120 countries. Most recently, the group has created a case-based online course for the World Health Organization (WHO) designed to educate providers throughout the world regarding antimicrobial stewardship. SASS has been named as a Center of Excellence by the IDSA and has also been designated a WHO Centre of Excellence for Antimicrobial Resistance and Stewardship.
PROJECT TEAM STRUCTURE
PROJECT TEAM STRUCTURE
Quattro teams, typically five to seven members, are led by only our most experienced people.
Having been in healthcare for decades, our founders know this industry. They personally lead Quattro’s analytic process, immersed from initial planning to project completion. Our leaders are not arms-length. On-target execution demands on-point project leadership.